v3.25.4
Shareholders' Deficit - Summary of Warrant Activity Associated with Equity Financings (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted Average Exercise Price Per Share, Exercised $ 5.09  
Warrants    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Warrants Outstanding, Beginning balance 1,160,560  
Number of Warrants Outstanding, Granted 1,127,040  
Number of Warrants Outstanding, Exercised 0  
Number of Warrants Outstanding, Canceled (911,544)  
Number of Warrants Outstanding Ending balance 1,376,056 1,160,560
Number of Warrants Outstanding, Exercisable 564,790  
Weighted Average Contractual Term (in years), Granted 4 years 10 months 13 days  
Weighted Average Contractual Term (in years), Outstanding 5 years 3 months 18 days 9 years 8 months 15 days
Weighted Average Contractual Term (in years), Exercisable 5 years 3 months 18 days  
Aggregate Intrinsic Value, Outstanding $ 0 $ 230
Aggregate Intrinsic Value, Granted 0  
Aggregate Intrinsic Value, Exercisable $ 373  
Weighted Average Exercise Price Per Share, Outstanding, Beginning balance $ 5.92  
Weighted Average Exercise Price Per Share, Granted 6.12  
Weighted Average Exercise Price Per Share, Canceled 6.17  
Weighted Average Exercise Price Per Share, Outstanding, Ending balance 5.91 $ 5.92
Weighted Average Exercise Price Per Share, Exercisable $ 5.54  
Warrants | Equity Financing    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Warrants Outstanding, Beginning balance 3,389,398  
Number of Warrants Outstanding, Granted 6,664,096  
Number of Warrants Outstanding, Exercised (265,725)  
Number of Warrants Outstanding Ending balance 9,787,769 3,389,398
Number of Warrants Outstanding, Exercisable 9,787,769  
Weighted Average Contractual Term (in years), Granted 4 years 5 months 12 days  
Weighted Average Contractual Term (in years), Outstanding 6 years 2 months 26 days 9 years 10 months 13 days
Weighted Average Contractual Term (in years), Exercisable 6 years 2 months 26 days  
Aggregate Intrinsic Value, Outstanding $ 373 $ 12,296
Aggregate Intrinsic Value, Exercisable $ 373  
Weighted Average Exercise Price Per Share, Outstanding, Beginning balance $ 1.83  
Weighted Average Exercise Price Per Share, Granted 3.3  
Weighted Average Exercise Price Per Share, Exercised 3.13  
Weighted Average Exercise Price Per Share, Outstanding, Ending balance 2.8 $ 1.83
Weighted Average Exercise Price Per Share, Exercisable $ 2.8